Rhinosinusitis Chronic
13
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.7%
1 terminated out of 13 trials
80.0%
-6.6% vs benchmark
15%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (13)
Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate
This Study Aims to Assess the Impact of 50°C Saline Irrigation on the Overall Intraoperative Blood Loss and Surgical Visualization During Endoscopic Sinus Surgery for Rhinosinusitis.
BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry
Impact of Symbiofilm On Nasal Microbiota
Prevalence of ENT Diseseas
Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis
Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study.
Role of Imaging in Complications of Sinusitis
TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality
Sinolpan® Pharmacy Non-interventional Study - Quality of Live
Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
Effectiveness of Endonasal Polymeric Implant for Chronic Rhinosinusitis
Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells